📰 Optimizerx Co News
Optimizerx Co News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Optimizerx Co. Real-time updates on events, politics, business and more.
May 28, 2024
Millrace Asset Group Inc. purchased a new stake in OptimizeRx Co. (NASDAQ:OPRX – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 133,936 shares of the company’s stock, valued at approximately $1,917,000. OptimizeRx makes up about 1.9% of Millrace […]
April 19, 2024
OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among analysts that […]
April 2, 2024
Citigroup Inc. decreased its position in shares of OptimizeRx Co. (NASDAQ:OPRX – Free Report) by 45.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,189 shares of the company’s stock after selling 5,070 shares during the period. Citigroup Inc.’s […]
March 25, 2024
OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the six analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among brokerages that […]
February 4, 2024
OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price objective among analysts […]
February 4, 2024
L2 Asset Management LLC purchased a new position in OptimizeRx Co. (NASDAQ:OPRX – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 12,170 shares of the company’s stock, valued at approximately $95,000. Other institutional investors and hedge funds also […]
January 17, 2024
Jacob Asset Management of New York LLC lifted its stake in shares of OptimizeRx Co. (NASDAQ:OPRX – Free Report) by 30.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 370,330 shares of the company’s stock after purchasing an additional 85,720 shares during […]
November 27, 2023
Avenir Corp cut its holdings in OptimizeRx Co. (NASDAQ:OPRX – Free Report) by 7.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 381,660 shares of the company’s stock after selling 32,913 shares during the quarter. OptimizeRx makes up 0.5% of Avenir Corp’s holdings, […]
November 21, 2023
OptimizeRx Co. (NASDAQ:OPRX – Free Report) – William Blair raised their FY2023 earnings per share (EPS) estimates for OptimizeRx in a research note issued to investors on Wednesday, November 15th. William Blair analyst R. Daniels now anticipates that the company will post earnings per share of ($0.57) for the year, up from their prior forecast […]
September 12, 2023
Shares of OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) have been given a consensus recommendation of “Buy” by the eight research firms that are covering the stock, MarketBeat.com reports. Eight analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have covered the stock in the last year […]